SCHEMBL6781046

SCHEMBL6781046

COc1ccc(N(Cc2ccccc2-c2ccccc2)C(=O)c2ccc(OC)cc2OC)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.49
▸ KMT2A Q03164 3/20 0.49
▸ TAS1R3 Q7RTX0 1/20 0.49
▸ TAS1R1 Q7RTX1 1/20 0.49
▸ PDK1 Q15118 3/20 0.49
▸ ALDH1A1 P00352 4/20 0.47
▸ LMNA P02545 4/20 0.47
▸ HTT P42858 2/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ LTB4R2 Q9NPC1 1/20 0.46
▸ PKM P14618 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ PTGES O14684 1/20 0.45
▸ ALOX5 P09917 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.44
▸ TP53 P04637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6778305 0.85 LTB4R2 (0.52) MEN1KMT2ATAS1R3TAS1R1ALDH1A1
SCHEMBL6780398 0.84 LMNA (0.51) PDK1ALDH1A1LMNALTB4R2PTGES
SCHEMBL6778364 0.84 PTGES (0.56) MEN1KMT2APDK1ALDH1A1LMNA
SCHEMBL6779695 0.83 LMNA (0.49) MEN1KMT2ATAS1R3TAS1R1PDK1
SCHEMBL6784549 0.82 LTB4R2 (0.48) MEN1KMT2APDK1ALDH1A1LMNA
SCHEMBL6780300 0.79 LTB4R2 (0.46) MEN1KMT2APDK1ALDH1A1LMNA
SCHEMBL6775891 0.79 PDK1 (0.47) MEN1KMT2ATAS1R3TAS1R1PDK1
SCHEMBL6774057 0.78 LMNA (0.46) MEN1KMT2APDK1ALDH1A1LMNA
SCHEMBL6774704 0.77 TSHR (0.47) MEN1KMT2ATAS1R3TAS1R1PDK1
SCHEMBL6774063 0.77 LTB4R2 (0.50) MEN1KMT2ATAS1R3TAS1R1PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT MEN1 4612/4885KMT2A 1440/4885TAS1R3 3434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback